Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results